Procter & Gamble Health Ltd
NSE:PGHL

Watchlist Manager
Procter & Gamble Health Ltd Logo
Procter & Gamble Health Ltd
NSE:PGHL
Watchlist
Price: 5 859.5 INR 0.27%
Market Cap: 97.3B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

PGHL Price Targets Summary
Procter & Gamble Health Ltd

There are no price targets for PGHL.
PGHL Lowest Forecast
Wall Street Target
Not Available
PGHL Average Forecast
Wall Street Target
Not Available
PGHL Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Procter & Gamble Health Ltd Competitors:
Price Targets
REC
Recordati Industria Chimica e Farmaceutica SpA
12% Upside
069620
Daewoong Pharma
40% Upside
688185
CanSino Biologics Inc
18% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
21% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
12% Upside
069620
Daewoong Pharma
40% Upside
688185
CanSino Biologics Inc
18% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
21% Upside
PAHC
Phibro Animal Health Corp
29% Downside
SUPRIYA
Supriya Lifescience Ltd
19% Upside
D
DPHARMA
Duopharma Biotech Bhd
22% Upside

Revenue
Forecast

Revenue Estimate
Procter & Gamble Health Ltd

For the last 12 years the compound annual growth rate for Procter & Gamble Health Ltd's revenue is 6%. The projected CAGR for the next 2 years is 10%.

6%
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Procter & Gamble Health Ltd

For the last 12 years the compound annual growth rate for Procter & Gamble Health Ltd's operating income is 13%. The projected CAGR for the next 2 years is 14%.

13%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Procter & Gamble Health Ltd

For the last 12 years the compound annual growth rate for Procter & Gamble Health Ltd's net income is 10%. The projected CAGR for the next 2 years is 16%.

10%
Past Growth
16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
PGHL intrinsic value, competitors valuation, and company profile.
DCF Valuation
PGHL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PGHL stock valuation using valuation multiples.
Wall Street Estimates
PGHL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PGHL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PGHL's stock price target?
Not Available

PGHL doesn't have any price targets made by Wall Street professionals.

What is Procter & Gamble Health Ltd's Revenue forecast?
Projected CAGR
10%

For the last 12 years the compound annual growth rate for Procter & Gamble Health Ltd's revenue is 6%. The projected CAGR for the next 2 years is 10%.

What is Procter & Gamble Health Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 12 years the compound annual growth rate for Procter & Gamble Health Ltd's operating income is 13%. The projected CAGR for the next 2 years is 14%.

What is Procter & Gamble Health Ltd's Net Income forecast?
Projected CAGR
16%

For the last 12 years the compound annual growth rate for Procter & Gamble Health Ltd's net income is 10%. The projected CAGR for the next 2 years is 16%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 265,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.